Ratings Moves: GES,...
Health Care: Drugs
Chembio Diagnostics Inc. (CEMI: NASDAQ)
$4.58 0.15 | 3.36%
05/21/13 - 03:56 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 25.61M | 19.39M | 16.70M | 13.83M |
| Cost of Sales | 14.30M | 9.56M | 8.32M | 7.61M |
| Gross Operating Profit | 11.31M | 9.83M | 8.38M | 6.22M |
| Selling, General, and Administrative Expenses | 4.85M | 3.42M | 2.94M | 2.66M |
| Research & Development | 4.49M | 4.88M | 2.59M | 2.88M |
| Operating Income before D & A (EBITDA) | 1.98M | 1.53M | 2.86M | 679.66K |
| Depreciation & Amortization | 523.28K | 437.83K | 283.74K | 362.34K |
| Interest Income | 7.91K | 6.30K | 4.15K | 9.03K |
| Other Income - Net | 0.00 | 0.00 | -3.92K | -6.70K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 1.46M | 1.09M | 2.57M | 319.66K |
| Interest Expense | 9.50K | 18.62K | 14.73K | 10.60K |
| Pre-Tax Income | 1.45M | 1.08M | 2.56M | 309.06K |
| Income Taxes | 509.24K | -5.13M | 45.82K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 941.28K | 0.00 | 0.00 | 309.06K |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 941.28K | 0.00 | 0.00 | 309.06K |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 941.28K | 6.21M | 2.51M | 309.06K |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
941.28K | 0.00 | 0.00 | 309.06K |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 941.28K | 0.00 | 0.00 | 309.06K |
| Basic EPS from Continuing Ops. | 0.12 | 0.80 | 0.32 | 0.00 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.12 | 0.80 | 0.32 | 0.00 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.12 | 0.80 | 0.32 | 0.00 |
| Basic Normalized Net Income/Share | 0.12 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | 0.11 | 0.72 | 0.32 | 0.00 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.11 | 0.72 | 0.32 | 0.00 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.11 | 0.72 | 0.32 | 0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.11 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CEMI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
Latest CEMI Headlines from TheStreet
- Chembio Enters International Distribution And Assembly Agreement With Labtest 05.21.13 | 08:05 am
- Chembio Sponsors 28th Annual AIDS Walk New York As Co-Chair Advocate 05.17.13 | 08:05 am
- Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor For Development Of Rapid, Point-of-Care Influenza Immunity Test 05.16.13 | 08:05 am
- Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity And Specificity In Evaluation By Mexico's Institute Of Epidemiological Diagnosis And Reference 05.14.13 | 09:05 am
- Chembio Diagnostics Reports First Quarter 2013 Financial Results 05.09.13 | 08:05 am
- Chembio Diagnostics Supports Recent USPSTF Routine Testing Recommendations 05.02.13 | 09:05 am
- Chembio To Host Conference Call To Discuss First Quarter 2013 Financial Results 04.25.13 | 08:04 am
- Chembio Commences CLIA Waiver Studies For DPP(R) HIV 1/2 Assay 04.18.13 | 08:04 am
- Chembio Announces Closing Of $6 Million Public Offering Of Common Stock 04.03.13 | 03:04 pm
- Chembio Announces Pricing Of $6.0 Million Public Offering Of Common Stock 03.28.13 | 06:03 am
Press Releases for CEMI
- Chembio Diagnostics, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 02.06.12 | 10:02 am
- Chembio Presenting At Biotech Conference - PR Newswire 01.09.12 | 08:01 am
- Chembio Provides Business Update - PR Newswire 01.03.12 | 08:01 am
- Chembio To Host Conference Call To Discuss 3rd Quarter 2011 Financial Results - PR Newswire 10.20.11 | 08:10 am
- Chembio Diagnostics' CFO Richard J. Larkin Among The Recipients Of "2011 CFO Of The Year" Award From Long Island Business News - PR Newswire 08.18.11 | 08:08 am
- Chembio To Host Conference Call To Discuss 2nd Quarter 2011 Financial Results - PR Newswire 07.20.11 | 08:07 am
- Chembio To Sponsor AIDS Walk New York 2011 - PR Newswire 05.11.11 | 08:05 am
- Chembio Corrects Previous Press Release - PR Newswire 04.21.11 | 05:04 pm
- Chembio Files PMA Module With FDA For DPP® HIV Test - PR Newswire 04.19.11 | 08:04 am
Partner Headlines for CEMI
- Q3: DPP Sales Up 49% Despite Revenue Miss - Analyst Blog - Zacks 11.13.12 | 06:11 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 06:08 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 03:08 pm
- Med-tech Companies to Watch in 2012 - Analyst Blog - Zacks 01.09.12 | 07:01 am
- Q1 2011 Financial Results... - Analyst Blog - Zacks 05.06.11 | 09:05 am
- Major Milestone for Chembio - Analyst Blog - Zacks 07.01.10 | 06:07 pm
- Chembio Diagnostics Inc. - Bull of the Day - Zacks 06.22.10 | 01:06 am
